Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Constantina Papacharalambous"'
Autor:
Roidoula Papamichali, Georgios K. Koukoulis, P. Panagiotidis, A. Androulaki, Constantina Papacharalambous, Μ. G. Ioannou, Evangelos Kouvaras
Publikováno v:
Journal of Hematopathology. 6:231-235
Anaplastic lymphoma kinase-positive diffuse large B cell lymphoma represents a distinct subtype of diffuse large B cell lymphoma with a characteristic morphology, a distinct immunophenotypic profile, and recurrent cytogenetic/molecular genetic abnorm
Autor:
Maria, Ioannou, Roidoula, Papamichali, Maria, Samara, Efrosini, Paraskeva, Constantina, Papacharalambous, Korina, Baxevanidou, George, Koukoulis
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(3)
V600E is the most common activating BRAF mutation in colorectal carcinomas (CRCs). It is a crucial biomarker for patient selection and response to targeted therapy with BRAF V600E inhibitors. Previous studies using immunohistochemistry (IHC) have sho
Autor:
Panagiota Matsouka, George K. Koukoulis, Constantina Papacharalambous, Eleftheria Gletsou, Evangelos Kouvaras, Maria Ioannou, Jon van der Walt
Publikováno v:
Journal of Hematopathology. 4:227-231
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma that differs from classic Hodgkin lymphoma with respect to histological and clinical presentations. This type of lymphoma typically affects predictable lymp
Autor:
Maria, Ioannou, Efrosyni, Paraskeva, Korina, Baxevanidou, George, Simos, Roidoula, Papamichali, Constantina, Papacharalambous, Maria, Samara, George, Koukoulis
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 20(3)
Colorectal cancer (CRC) is the third most common cancer worldwide and despite the abundance of molecular pathways and markers continually being reported, the mortality rates remain high. Hypoxia inducible factor 1alpha (HIF-1α) plays a major role in